Robustness and System Suitability - Analytical Validation - page 100

20. FDA ORA Laboratory Procedure, #ORA-LAB.5.4.5, Revised 09/09/2005. See also
http://www.fda.gov/ora/science_ref/lm/vol2/section/5_04_05.pdf.
21. Pharm. Forum , 31(3), <621> Chromatography 825, May-June 2005.
22. Pharm. Forum , 31(6), <621> Chromatography 1681, Nov.-Dec. 2005.
23. Neue, N. D., McCabe, D., Ramesh, V., Pappa, H., and DeMuth, J., Stimuli to the revi-
sion process: Transfer of HPLC procedures to suitable columns of reduced dimensions
and particle sizes. Pharm. Forum 35(6). April 2010.
24. Swartz, M. E., Unpublished data on the analysis of tricyclic amines at pH 7.2.
25. Swartz, M. E. and Krull, I. S., Developing and Validating Stability Indicating Methods.
LCGC 23(6), 46, June 2005.
26. Swartz, M. E., UPLC: An introduction and review. J. Liq. Chromatogr. Rel. Technol .,
28(7-8), 1253-1263, 2005.
27. Separation Science Re-Defined, Supplement to LCGC, May 2005.
28. Mazzeo, J., Neue, U., Kele, M., and Plumb, R., Advancing LC Performance with Smaller
Particles and Higher Pressure. Anal. Chem ., 77(23), 460A-467A, 2005.
29. The Quest for Ultra Performance in Liquid Chromatography—Origins of UPLC
Technology, Waters Corporation. See http://www.waters.com/waters/partDetail.htm?ci
d=511539&id=38628&ev=10120661&locale=en_US.
30. Beginners Guide to UPLC—Ultra-Performance Liquid Chromatography. Waters
Corporation. See http://www.waters.com/waters/partDetail.htm?cid=511539&id=3862
9&ev=10120684&locale=en_US.